Chris Labaki

11PUBLICATIONS
83CO-AUTHORS
Predictive and prognostic markersSensory processes, perception and performanceMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 20, 2026
Single-cell epigenetic profiling reveals a tumor-intrinsic interferon response program in ccRCC tied to poor prognosis and BAP1 loss.

Sabrina Y Camp, Meng Xiao He, Michael S Cuoco

|Nov 19, 2025
Prospective Validation of the First US FDA-Approved Computer-Aided Quality Assessment Tool for Colonoscopy: An Initial Clinical Experience.

Todd A Brenner, Chris Labaki, Joseph D Feuerstein

|Jan 09, 2025
Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma.

Tejas Jammihal, Renee Maria Saliby, Chris Labaki

|Nov 28, 2024
Single-cell epigenetic profiling reveals an interferon response-high program associated with BAP1 deficiency in kidney cancer.

Sabrina Y Camp, Meng Xiao He, Michael S Cuoco

|Mar 09, 2022
Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19.

Samuel M Rubinstein, Divaya Bhutani, Ryan C Lynch

|Feb 08, 2022
Linking a Trio of Molecular Features in Clear-Cell Renal Cell Carcinoma.

Chris Labaki, Eliezer M Van Allen, Toni K Choueiri

Pageof 2

Frequent Collaborators

4 joint publications

Ziad Bakouny

4 joint publications

Toni K Choueiri

3 joint publications

Eliezer Van Allen

3 joint publications

Sabina Signoretti